BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 34638293)

  • 1. Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer.
    Hussein S; Khanna P; Yunus N; Gatza ML
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications.
    Gandhi N; Das GM
    Cells; 2019 Jan; 8(2):. PubMed ID: 30691108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming of mitochondrial respiration in metastatic cancer.
    Herst PM; Grasso C; Berridge MV
    Cancer Metastasis Rev; 2018 Dec; 37(4):643-653. PubMed ID: 30448881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
    Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D
    Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
    Padua MB; Bhat-Nakshatri P; Anjanappa M; Prasad MS; Hao Y; Rao X; Liu S; Wan J; Liu Y; McElyea K; Jacobsen M; Sandusky G; Althouse S; Perkins S; Nakshatri H
    Breast Cancer Res; 2018 May; 20(1):35. PubMed ID: 29720215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis.
    Ohshima K; Morii E
    Metabolites; 2021 Jan; 11(1):. PubMed ID: 33401771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Reprogramming in Triple-Negative Breast Cancer.
    Sun X; Wang M; Wang M; Yu X; Guo J; Sun T; Li X; Yao L; Dong H; Xu Y
    Front Oncol; 2020; 10():428. PubMed ID: 32296646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of Reprogramming Breast Cancer Metabolism.
    Wang YP; Lei QY
    Adv Exp Med Biol; 2017; 1026():217-232. PubMed ID: 29282686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox and metabolic reprogramming in breast cancer and cancer-associated adipose tissue.
    Zakic T; Pekovic-Vaughan V; Cvoro A; Korac A; Jankovic A; Korac B
    FEBS Lett; 2023 Dec; ():. PubMed ID: 38140817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors.
    Bacci M; Giannoni E; Fearns A; Ribas R; Gao Q; Taddei ML; Pintus G; Dowsett M; Isacke CM; Martin LA; Chiarugi P; Morandi A
    Cancer Res; 2016 Mar; 76(6):1615-26. PubMed ID: 26795347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming in cancer: Mechanisms and therapeutics.
    Nong S; Han X; Xiang Y; Qian Y; Wei Y; Zhang T; Tian K; Shen K; Yang J; Ma X
    MedComm (2020); 2023 Apr; 4(2):e218. PubMed ID: 36994237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging functional roles of nuclear receptors in breast cancer.
    Doan TB; Graham JD; Clarke CL
    J Mol Endocrinol; 2017 Apr; 58(3):R169-R190. PubMed ID: 28087820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
    Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
    J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies.
    Xu R; Yang J; Ren B; Wang H; Yang G; Chen Y; You L; Zhao Y
    Front Oncol; 2020; 10():572722. PubMed ID: 33117704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating metabolic reprogramming and metabolic imaging to predict breast cancer therapeutic responses.
    Liu Y; Zhou Q; Song S; Tang S
    Trends Endocrinol Metab; 2021 Oct; 32(10):762-775. PubMed ID: 34340886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance.
    Lei P; Wang W; Sheldon M; Sun Y; Yao F; Ma L
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of MicroRNAs in Lung Cancer Metabolism.
    Azizi MIHN; Othman I; Naidu R
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches.
    Navarro C; Ortega Á; Santeliz R; Garrido B; Chacín M; Galban N; Vera I; De Sanctis JB; Bermúdez V
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer.
    Tan YT; Lin JF; Li T; Li JJ; Xu RH; Ju HQ
    Cancer Commun (Lond); 2021 Feb; 41(2):109-120. PubMed ID: 33119215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.